PRESENTATION

Q3 2023 — Presentation

Q3 2023PDF · 33 pages1.5 MB
Presentation to Investors and Analysts
HSBC Holdings plc 3Q23 Results

-- 1 of 33 --

Appendix	4Q22 results	Strategy 	Summary
Our purpose, values and ambition support the execution of our strategy
Opening up a world of opportunity	Our purpose
Our values
Our strategy
Our ambition To be the preferred international financial partner for our clients
We value difference 	We succeed together 	We take responsibility 	We get it done
Focus on our strengths 	Digitise at scale 	Energise for growth 	Transition to net zero

-- 2 of 33 --

2
Appendix	3Q23 results
Business highlights
Reported PBT
$29.4bn
9M22: $12.0bn
RoTE
17.1%
9M22: 11.0%
RoTE excludes strategic transactions1
9M23 financials and capital
distributions
DPS (declared)
$0.30 per share
9M22: $0.09 per share
Share buybacks
announced
$7bnup
to
Acquired Citi’s
Retail Wealth
business in
mainland China
c.$3.6bn in assets
and deposits
Wealth customers
across 11 major cities
Wholesale transaction banking
revenue2
7.6 	8.0
5.9
12.2
9M22 	9M23
NII
Non-NII
$13.5bn
$20.2bn
+50%
0.5 	0.5
1.0 1.1
3Q22 	3Q23
Wealth
deposits 4
Invested
assets
$1.5tn $1.6tn
+12%
+$11bn
Growth in Asia and UK WPB
balances vs. 3Q22
Investment in Wealth	Hong Kong insurance
manufacturing new business
CSM5
9M22 	9M23
$0.8bn
$1.1bn
+40%
Wealth balances3 	Mortgages in Asia and the UK
o/w Asia: $6bn
o/w UK: $5bn
This presentation, unless otherwise stated, is presented on a constant currency basis
Figures throughout this presentation may be subject to rounding adjustments and therefore may not sum precisely to totals given in charts, tables or commentary
6%
>100%
16%
4%
Group 3Q23 new business CSM of
$587m, up $246m (72%) vs. 2Q23

-- 3 of 33 --

3
Appendix	3Q23 results
91 %
3Q23 results summary
 	Revenue of $16.2bn, up $4.6bn (40%):
 	NII of $9.2bn, up $1.3bn vs. 3Q22 due to interest rate rises, stable
vs. 2Q23
 	Non-NII of $6.9bn, up $3.3bn, primarily due to: (i) the non-
recurrence of a $2.5bn impairment in 3Q22 relating to the planned
sale of our retail banking operations in France; (ii) $1.6bn higher
revenue offset into non-NII from the central costs of funding GBM
trading activity; (iii) offset by $0.6bn Treasury disposal losses taken
for hedging and risk management purposes ‡
 	Banking NII of $11.5bn
 	ECL charge of $1.1bn, $0.5bn relates to our mainland China CRE
portfolio
 	Costs of $8.0bn, up 1% as lower restructuring costs were offset by
higher performance-related pay accrual, technology spending and
Innovation Banking costs
 	Customer loans broadly stable vs. 2Q23 as softer corporate loan
demand in Hong Kong was partly offset by growth in WPB
 	Customer deposits stable vs. 2Q23
 	CET1 ratio of 14.9%; TNAV per share of $7.96, up $0.12 vs. 2Q23
mainly due to retained profits
 	Third interim dividend of $0.10 per share; announcing an up to
$3bn share buyback
Variances on this slide are vs. 3Q22 unless otherwise stated
* Reconciliation on slide 28
‡ These losses do not materially impact CET1 capital, TNAV or TNAV per share as they have already been taken through reserves
$m 	3Q23 	3Q22 	Δ (%)
NII 	9,248 	7,998 	16 %
Non-NII 	6,913 	3,577 	93 %
Revenue 	16,161 	11,575 	40 %
ECL 	(1,071) 	(1,103) 	3 %
Costs 	(7,968) 	(7,902) 	(1)%
Associates 	592 	554 	7 %
Constant currency PBT 	7,714 	3,124 	>100%
FX translation 	— 	105 	—
Reported PBT 	7,714 	3,229 	>100%
Tax 	(1,448) 	(572) 	>(100)%
Profit attributable to ordinary shareholders 	5,619 	2,002 	>100%
Earnings per share, $ 	0.29 	0.10 	$0.19
EPS excluding material notable items*, $ 	0.27 	0.20
Dividend per share (declared), $ 	0.10 	— 	$0.10
RoTE (YTD, annualised), $ 	19.7 	9.4 	10.3ppts
Memo: notable items 6	
(317) 	(3,528)
$bn 	3Q23 	2Q23 	Δ (%)
Customer loans 	936 	940 	(0)%
Customer deposits 	1,563 	1,565 	(0)%
Reported RWAs 	840 	860 	(2)%
CET1 ratio 7, % 	14.9 	14.7 	0.2ppts
TNAV per share, $ 	$7.96 	$7.84 	$0.12
$0.07
o/w: Treasury security disposals	
(578)	
— 	>(100)%

-- 4 of 33 --

4
Appendix	3Q23 results
Revenue performance
3Q23 revenue 	3Q23 vs. 3Q22 	Revenue by global business, $bn
3.9
7.2
4.4
5.5
6.7
3.8
4.0
5.4
3.9
(0.6)
3Q22
(0.1)
2Q23
0.1
3Q23
11.6
16.6 16.2
+40%
GBM
CMB
WPB
Corporate Centre
71%
22%
2%
of which: GPS
GPS
GTRF
Credit and Lending
Other
Wealth
Other
$6,719m
$5,424m
$3,887m
$131m
$16,161m 	40%
$1,894m
$254m
$1,127m
$2,158m
$366m
$3,199m
$1,339m
$520m
$(457)m
MSS
WPB
CMB
GBM
Corp. Centre
Group
Banking
$928m
Other 	$(429)m
Personal Banking 	$5,282m
of which: Capital
Markets & Advisory
$2,158m
of which: FX
>100%
107
908
(114)
1,231
(127)
(139)
(133)
455
329
72
(223)
725
4,586
1,770*
(7)
o/w Treasury disposal
losses $(253)m
o/w Treasury disposal
losses $(190)m
o/w Treasury disposal
losses $(135)m
6 %
21 %
79 %
(1)%
(8)%
63 %
(26)%
(6)%
(13)%
27 %
41 %
40 %
>(100)%
* Variance largely due to the portion of an impairment in 3Q22 relating to the planned sale of our retail banking operations in France which was booked in WPB ($2.3bn)

-- 5 of 33 --

5
Appendix	3Q23 results
151bps
168bps 	169bps 172bps 	170bps
(2)bps
2,110 	2,116 	2,153 	2,172 	2,157
Net interest income and margin
 NII stable vs. 2Q23 on a constant currency basis
 Banking NII of $11.5bn, stable vs. 2Q23.
2Q23 included $0.4bn favourable 1H23 impact of
methodology changes which relate broadly equally
to 1Q23 and 2Q23
 NIM broadly stable vs. 2Q23
 FY23 guidance unchanged: expect NII >$35bn
and the revenue offset into non-NII from the central
costs of funding GBM trading activities to be in
excess of $7bn
Reported NII analysis
Discrete quarterly
NIM
Average interest earning
assets (AIEAs) ‡ , $bn:
8.7
0.1
(0.8)
3Q22
10.2
0.1
(1.3)
4Q22
10.3
0.1
(1.4)
1Q23
11.6
0.1
(2.4)*
2Q23
11.5
0.1
(2.4)
3Q23
8.0
9.0 	9.0
9.3 	9.2
NIM progression, bps
2Q23
43
Asset yields
(33)
Liability costs
(12)
Balance
sheet mix
3Q23
172 	170
Banking NII, $bn 8
Insurance NII, $bn
Central costs of
funding trading
activities, $bn 9
* 2Q23 central costs of funding trading income included $0.4bn reflecting the year-to-date impact of methodology changes
‡ 3Q23 includes c.$18bn insurance AIEAs and excludes c.$130bn period end trading, fair value and associated net asset balances
Group NII, $bn

-- 6 of 33 --

6
Appendix	3Q23 results
Non-NII
Group non-NII, $bn
2.1 1.7 	1.7
1.4
1.6 	1.5
0.4 0.4 0.4
0.5 0.6 0.5
1.0 0.9
0.7
3Q22 	2Q23 	3Q23
Other ‡
Global Payments Solutions
Global Trade and Receivables Finance
Wealth
Markets and Securities Services
 Constant currency non-NII up $3.3bn (93%) vs. 3Q22:
 	$2.3bn favourable movement in notable items and FX. 3Q22
included a $2.5bn impairment relating to the planned sale of
our retail banking business in France; 3Q23 included $0.6bn
Treasury disposal losses
 	$1.6bn increase in the revenue offset into non-NII from the
central costs of funding GBM trading activity
 	Other down $0.3bn, including lower Markets Treasury income
 $0.6bn of Treasury disposal losses associated with
enhancement of our structural interest rate hedge position:
 	Disposal proceeds will be reinvested into higher yielding or
higher duration assets. Disposal losses are forecast to be more
than recovered through NII, the majority of which will be
over the first five years
 	Modest benefit to CET1 ratio
 	Expect a further c.$0.4bn of these losses in 4Q23
Constant currency non-NII:
Product splits are shown on a reported FX basis
* 2Q23 included $0.4bn reflecting the year-to-date impact of methodology changes
 These losses do not materially impact CET1 capital, TNAV or TNAV per share as they have already been taken through reserves
‡ Other includes WPB Personal Banking, WPB Other, CMB Credit & Lending, CMB Other, GBM Banking (excl. GPS and GTRF),
GBM Other and Corporate Centre (excl. offset from central costs of funding trading income)
Notable items and FX:
Offset from central costs of
funding trading income:
3.6 	6.9	7.4
(2.6) 	(0.3)	(0.2)
0.8 	2.4	2.4*
vs. 3Q22
93%

-- 7 of 33 --

7
Appendix	3Q23 results
0.42 	0.57 	0.18 	0.36 	0.42
Credit performance
ECL charge trend, $m
ECL charge as a
% of average
gross loans and
advances 10
ECL charge by stage, $bn	ECL charge / (release) by entity, $m
Stage 1-2 	Stage 3 	Total
Wholesale 	0.1 	0.7 	0.8
Personal 	0.1 	0.1 	0.2
Total 	0.2 	0.9 1.1
 	$1.1bn charge, including $0.5bn relating
to mainland China CRE
 	YTD mainland China CRE charge $0.8bn
 	Low personal lending charge of $0.2bn
 	Low charge in the UK RFB driven by stage 1
and 2 releases as improved economic
expectations have led to favourable re-
weightings in our economic scenarios
 	Stage 3 balances of $19bn, down $1bn on
a reported basis vs. 2Q23 (2.0% of total
loans)
 	FY23 Group ECL guidance unchanged
at ~40bps10
* Mainland China CRE charge is on a reported basis and has not been currency adjusted in prior periods
‡ Hong Kong included a $503m charge relating to mainland China CRE
 Totals do not sum due to rounding
Mainland China
CRE charge*
363 	598 	62 	259 	503
3Q23 	2Q23
Asia (HBAP) 	748 	391
o/w Hong Kong ‡ 	659 	451
UK RFB (HBUK) 	58 	260
HSBC Bank plc (HBEU) 	80 	56
USA (HNAH) 	(15) 	33
Canada (HBCA) 	20 	10
Mexico (HBMX) 	158 	140
HSBC Bank Middle East (HBME) 	6 	7
Other 	16 	17
Total 	1,071 	914
1,103 1,467
440 914 	1,071
3Q22 	4Q22 	1Q23 	2Q23 	3Q23

-- 8 of 33 --

8
Appendix	3Q23 results
Memo: Hong
Kong at 2Q23
Hong
Kong
Mainland
China
Rest of
Group Total
Total	
8,076 	7,504 	5,146 	985 	13,635
Strong	
1,161 	1,197 	1,748 	111 	3,056
Good	
747 	643 	946 	431 	2,020
Satisfactory	
973 	925 	1,689 	233 	2,847
Sub-standard	
1,891 	1,485 	520 	191 	2,196
Credit impaired	
3,304 	3,254 	243 	19 	3,516
Allowance for ECL*	
(1,981) 	(2,031) 	(221) 	(18) 	(2,270)
Mainland China commercial real estate update
 	Total mainland China CRE exposure $13.6bn, down
$0.6bn vs. 2Q23 mainly due to write-offs and down $7.7bn
vs. FY21
Hong Kong booked exposures:
 	$7.5bn, down $0.5bn vs. 2Q23; $7.2bn drawn loans &
advances
 	Our exposure classified as strong, good and satisfactory
remained broadly stable vs. 2Q23:
 	c.50% is to state-owned enterprises; c.50% is primarily
lending to privately-owned enterprises that are not
residential property developers. This is reflected in the
minimal ECL allowance in this part of the portfolio
 	Given worsened market conditions, the management
assessed plausible downside scenario of c.$1bn ECL now
looks more realistic for FY23
 	YTD ECL charge of $0.8bn
 	FY23 Group ECL guidance of c.40bps unchanged10
Mainland China CRE exposures by booking location and credit quality
$m Total
exposure
Of which
not secured
ECL
allowance*
Sub-standard 	1,485 	1,075 	(71)
Credit impaired 	3,254 	2,588 	(1,893)‡
Total 	4,739 	3,663 	(1,964)
At 30 September 2023
Hong Kong booked sub-standard and credit impaired exposures
c.73%
coverage ratio
against not
secured, credit
impaired
exposures
Exposure in previous periods is shown on a reported FX basis
* ECL allowance shown on not secured exposures only
‡ 3Q23 ECL allowance and credit impaired exposures were reduced by c.$0.4bn vs. 2Q23 due to write-offs

-- 9 of 33 --

9
Appendix	3Q23 results
+1%
717
3Q22
1,223
4Q22
63
1Q23
10
2Q23
49
3Q23
7,902 	8,996 	7,618 	7,824 	7,968
+2%
7,356
6,926 	6,926
Costs
Operating expenses trend, $m
3Q23 vs. 3Q22 (constant currency), $m
Reported costs:
 	9M23 costs of $23.4bn, down 2% vs. 9M22, primarily
due to lower restructuring costs
 	9M23 cost-efficiency ratio of 44%, improved 22ppts vs.
9M22; 3Q23 CER of 49%, improved 18ppts vs. 3Q22
Constant currency basis:
 	3Q23 costs of $8.0bn, up 1% vs. 3Q22. Lower notable
items (largely restructuring costs) were offset by higher
performance-related pay accrual, technology spending and
Innovation Banking costs
Target basis guidance (reconciliation on slide 14):
 	c.4% cost growth in FY23, 1% higher than previously
guided due to higher technology and operations expenditure
 	Acquisition of SVB UK and related international investments
to increase costs by an additional c.1%
 	Potential for a further increase of c.1% as we consider
higher performance-related pay in 4Q23
 	Target basis: constant currency, excluding notable items and
the impact of retranslating 2022 results in hyperinflationary
economies at constant currency and costs associated with
SVB UK and related international investments
 	FY22 comparative: $29.8bn
208
221
200
7,902
3Q22
(668)
Notable items
(primarily
restructuring
costs)
Tech
spend
Performance-
related pay
105
Innovation
Banking
Other*
7,968
3Q23
+1%
o/w notable items
* Other includes inflation and the impact of re-translating 3Q22 costs in hyperinflationary economies at constant currency, partly offset by cost programme saves

-- 10 of 33 --

10
Appendix	3Q23 results
 	CET1 ratio up 0.2ppts as profit generation and lower
RWAs were offset by dividend accrual and the share
buyback announced at 2Q23
 	Declared ordinary dividends of $0.30 per share ($5.9bn)
in respect of 9M23, accrued $0.49 per share ($9.6bn)
 	We anticipate the share buyback announced of up to
$3bn to impact the CET1 ratio by around 40bps in 4Q23
Strategic transactions (see slide 18):
 	Continue to expect the planned sale of our retail banking
operations in France to close on 1 January 2024
 	Expect an up to $2.2bn impairment in 4Q23 which
will impact the CET1 ratio by around 30bps
 	Our banking business in Canada remains in held-for-sale,
expect the transaction to complete in 1Q24
 	Estimated gain on sale $5.5bn (as at 30-Sep-23),
which we will recognise through a combination of
Canada earnings from 30-Sep-23 until completion and
a remaining gain on sale at completion
 	Remain committed to consider payment of a $0.21
per share special dividend as a priority use of
proceeds in 1H24
Capital adequacy
Capital progression7
CET1 ratio7, %
0.7
0.1
2Q23 	Profits 11 	Dividend
accrual
Change in
RWAs
FX
translation
differences
2Q23
buyback
Other 	3Q23
14.7 (0.3) 	(0.0)
(0.3) 	(0.0)
14.9
126.4
859.5
124.8	CET1, $bn
RWAs, $bn 	840.0	(7.0)
(2.7) 	(0.6)	5.7 	(2.0)
(12.5)
(2.0)
3Q23 	2Q23 	3Q22
Common equity tier 1 capital, $bn 	125 	126 	111
RWAs, $bn 	840 	860 	828
CET1 ratio, % 	14.9 	14.7 	13.4
Leverage ratio exposure, $bn 	2,478 	2,498 	2,415
Leverage ratio, % 	5.7 	5.8 	5.4
Cumulative HTC&S unrealised pre-tax losses of $(5.9)bn at 3Q23 vs. $(6.2)bn at 2Q23, movement includes $0.6bn relating to the notable Treasury disposal losses taken during the quarter

-- 11 of 33 --

11
Appendix	3Q23 results
Summary
2 Good Wealth performance, particularly in Hong Kong. Continued investment, including the acquisition of
Citi’s retail wealth business in mainland China
1 	PBT of $7.7bn and annualised RoTE1 of 17.1% (excluding strategic transactions)
5 Strong capital position, CET1 ratio of 14.9%; further up to $3bn buyback announced which we aim to
complete before our FY23 results announcement; third quarterly interim dividend of $0.10 per share
4 Mortgage growth in Asia of $6bn and the UK of $5bn vs. 3Q22 has been offset by softer corporate loan
demand
3 $0.5bn ECL charge on our mainland China CRE portfolio. FY23 Group ECL guidance unchanged at c.40bps of
average loans10

-- 12 of 33 --

Appendix

-- 13 of 33 --

13
Appendix	3Q23 results
Group guidance summary
Revised guidance
Lending 	Cautious outlook on loan growth in the short term; expect mid-single digit percentage annual loan growth in the medium to long term
CET1 	Manage in 14-14.5% target range in the medium term; aim to manage range down further longer term
Asia as a % of Group TE13 	c.50% medium to long term14
ECL 	FY23 ECL charge of around 40bps 10 ; through-the-cycle planning range of 30-40bps
Previous guidance
Costs
Targeting c.3% cost growth vs. FY22 on a target basis, plus c.1% for
additional costs relating to the acquisition of SVB UK and related
international investments
Expect c.4% cost growth vs. FY22 on a target basis (reconciliation
on slide 14). Costs relating to the acquisition of SVB UK and related
international investments will add an additional c.1%
Potential for a further increase of c.1% due to higher PRP in 4Q23
Updates to guidance
Existing Group guidance
RoTE 	RoTE in the mid-teens for 2023 and 202412
NII 	FY23 NII >$35bn and the revenue offset into non-NII from the central costs of funding GBM trading activities to be in excess of $7bn
Dividend payout ratio of 50% for 2023 and 202415	
Dividends
Existing guidance

-- 14 of 33 --

14
Appendix	3Q23 results
Cost target basis reconciliation
$m 	3Q23 	2Q23 	1Q23 	4Q22 	3Q22 	9M23 	9M22 	FY22
Reported 	7,968 	7,871 	7,586 	8,781 	7,793 	23,425 	23,920 	32,701
Currency impact 	— 	(47) 	32 	215 	109 	— 	(486) 	(392)
Constant currency 	7,968 	7,824 	7,618 	8,996 	7,902 	23,425 	23,434 	32,309
Notable items 16 	(48) 	(9) 	(63) 	(1,223) 	(717) 	(120) 	(1,726) 	(2,925)
Impact of retranslating
results of hyperinflationary
economies at constant
currency
— 	63 	69 	121 	128 	— 	287 	418
SVB UK and related
international investments (105) 	(67) 	— 	— 	— 	(172) 	— 	—
Target basis 	7,815 	7,811 	7,625 	7,894 	7,312 	23,134 	21,995 	29,802
Note: Table uses 3Q23 average FX rates for all quarters and 9M23 average rates for 9M22. FY22 uses 9M23 rates for 1Q22-3Q22 and Sep-23 average rates for 4Q22
FY23 cost target basis:
 	Now expect c.4% cost growth on a target basis (constant currency, excluding notable items and the impact of retranslating 2022 results in
hyperinflationary economies at constant currency). This is c.1% higher than previously guided due to higher technology and operations expenditure
 	We continue to expect the acquisition of SVB UK and related international investments to increase costs by an additional c.1%
 	In addition, there may be a further increase of c.1% as we consider a potential increase in performance-related pay based on the out-turn of our
performance and ongoing execution of our strategy in 4Q23
 	The relevant FY22 comparative is $29.8bn

-- 15 of 33 --

15
Appendix	3Q23 results
Share count, m 	3Q22
Capital, leverage and liquidity7
.
Key financial metrics
Reported results, $m 	3Q23 	2Q23 	3Q22
NII 	9,248 	9,305 	8,006
Other Income 	6,913 	7,400 	3,502
Revenue 	16,161 	16,705 	11,508
ECL 	(1,071) 	(913) 	(1,068)
Costs 	(7,968) 	(7,871) 	(7,793)
Associate income 	592 	850 	582
Profit before tax 	7,714 	8,771 	3,229
Tax 	(1,448) 	(1,726) 	(572)
Profit after tax 	6,266 	7,045 	2,657
Profit attributable to ordinary shareholders (PAOS) 	5,619 	6,639 	2,002
Basic EPS, $ 	0.29 	0.34 	0.10
DPS (in respect of the period), $ 	0.10 	0.10 	—
Net interest margin (annualised), % 	1.70 	1.72 	1.51
Reported balance sheet, $bn 	3Q23 	2Q23 	3Q22
Total assets 	3,021 	3,041 	2,975
Net loans and advances to customers 	936 	960 	966
Customer accounts 	1,563 	1,596 	1,567
Quarterly average interest-earning assets 	2,157 	2,172 	2,110
Reported loan/deposit ratio 	59.9 	60.1 	61.6
Ordinary shareholders’ equity (NAV) 	165 	165 	149
Tangible ordinary shareholders’ equity (TNAV) 	153 	153 	138
NAV per share, $ 	8.56 	8.44 	7.53
TNAV per share, $ 	7.96 	7.84 	7.01
Alternative performance measures, $m 	3Q23 	2Q23 	3Q22
Constant currency NII 	9,248 	9,208 	7,998
Constant currency other income 	6,913 	7,399 	3,577
Constant currency revenue 	16,161 	16,607 	11,575
Constant currency ECL 	(1,071) 	(914) 	(1,103)
Constant currency costs 	(7,968) 	(7,824) 	(7,902)
Constant currency associate income 	592 	829 	554
Constant currency profit before tax 	7,714 	8,698 	3,124
PAOS excl. goodwill and other intangible impairment 	5,626 	6,650 	2,445
Return on average tangible equity (annualised), % 	14.6 	17.1 	6.8
Return on average equity (annualised), % 	13.5 	15.9 	5.2
Constant currency net loans and advances to customers, $bn 	936 	940 	999
Constant currency customer accounts, $bn 	1,563 	1,565 	1,621
Cost efficiency ratio, % 	49.3 	47.1 	68.3
ECL as a % of average gross loans and advances to customers,
annualised % 0.45 	0.38 	0.43
3Q23 	2Q23 	3Q22
Risk-weighted assets, $bn 	860 	828
CET1 ratio, % 	14.9 	14.7 	13.4
Total capital ratio, % 	19.7 	19.8 	18.1
Leverage ratio, % 	5.8 	5.4
High-quality liquid assets (liquidity value), $bn 	631 	663
Liquidity coverage ratio, % 	132 	133
840
5.7
641
134
3Q23 	2Q23
Basic number of ordinary shares outstanding 	19,275 	19,534 	19,738
Basic number of ordinary shares outstanding and dilutive
potential ordinary shares
19,426 	19,679 	19,857
Average basic number of ordinary shares outstanding 	19,404 	19,662 	19,752

-- 16 of 33 --

16
Appendix	3Q23 results
Notable items
Notable items (reported basis), $m 	3Q23 	2Q23 	1Q23 	4Q22 	3Q22
Revenue 	(268) 	(241) 	3,577 	(320) 	(2,691)
o/w: Disposals, acquisitions and related costs* 	310 	(241) 	3,562 	(71) 	(2,378)
o/w: Fair value movements on financial instruments 	— 	— 	15 	35 	(282)
o/w: Restructuring and other related costs 	— 	— 	— 	(284) 	(31)
o/w: Disposal losses on Markets Treasury repositioning 	(578)‡ 	— 	— 	— 	—
Costs 	(49) 	(10) 	(61) 	(1,169) 	(691)
o/w: Impairment of non-financial items 	— 	— 	— 	— 	—
o/w: Restructuring and other related costs 	30 	47 	— 	(1,160) 	(682)
Total 	(317) 	(251) 	3,516 	(1,489) 	(3,382)
Memo: Notable items on a constant currency basis	
(317)	
(250)	
3,608	
(1,565)	
(3,528)
o/w: Disposals, acquisitions and related costs 	(79) 	(57) 	(61) 	(9) 	(9)
* Includes FV gains on FX hedges related to the planned sale of our banking business in Canada, including $214m in 3Q23
‡ $339m of the losses were booked in Asia

-- 17 of 33 --

17
Appendix	3Q23 results
Net interest margin
3Q22 	4Q22 	1Q23 	2Q23 	3Q23 % of 3Q23
Group NII
% of 3Q23
Group
AIEA
The Hongkong and
Shanghai Banking
Corporation (HBAP)*
1.66% 	1.94% 	1.83% 	1.83% 	1.85% 	46% 	43%
HSBC Bank plc 	0.44% 	0.50% 	0.59% 	0.60% 	0.53% 	7% 	22%
HSBC UK Bank plc
(UK RFB) 1.99% 	2.19% 	2.33% 	2.49% 	2.41% 	27% 	19%
HSBC North
America Holdings,
Inc
1.16% 	1.16% 	1.15% 	1.01% 	0.87% 	4% 	8%
* In 9M23, c.60% of the interest expense relating to the central costs of trading income
was booked in HBAP
Quarterly NIM by key legal entity 	Key rates (quarter averages), bps
164
368
303
400
482 	497
219
392
452
499 526 	533
162
283
385
445
516 	525
3Q22 	4Q22 	1Q23 	2Q23 	3Q23 	4Q23 QTD
1M HIBOR 	Fed effective rate 	BoE Bank rate
Source: Bloomberg
* At 27 October 2023

-- 18 of 33 --

18
Appendix	3Q23 results
Canada and France disposals
Banking business in Canada
9M23
NII 	1.0
Non-NII 	0.5
Revenue 	1.5
ECL 	(0.0)
Costs 	(0.8)
PBT 	0.7
RWA 	31.2
Customer loans (reported in HFS) 	54.6
Customer accounts (reported in HFS) 	59.2
 	Our banking business in Canada remains in held-for-sale. We expect the
transaction to complete in 1Q24 for a base cash consideration of CAD13.5bn for
the issued common equity of HSBC Canada
 	Estimated gain on sale $5.5bn (as at 30-Sep-23), which we will recognise through
a combination of Canada earnings from 30-Sep-23 until completion and a
remaining gain on sale at completion
 	Expected CET1 ratio impact of around 130bps. This may be reduced by the
$0.21 per share special dividend which we remain committed to consider as a
priority use of the proceeds in 1H24
Financials are shown on a reported FX basis
 	During 3Q23, we revised the terms for the planned sale, including the retention of
$7.4bn loans that were originally planned to transfer on completion of the sale
 	Continue to expect the sale to complete on 1 January 2024
 	Expect an up to $2.2bn impairment in 4Q23 which will impact the CET1 ratio
by around 30bps
HSBC Bank Canada selected financial information, $bn
Retail banking operations in France
9M23
NII 	0.1
Non-NII 	0.1
Revenue 	0.2
ECL 	0.0
Costs 	(0.4)
PBT 	(0.2)
RWA 	4.6
Customer loans 	16.4
Customer accounts 	22.6
France retail selected financial information, $bn
Costs
 	Around $0.3bn of operating expenses from the businesses ($0.2bn Canada, $0.1bn
France) relate to Group recharges and other costs and will not transfer as part of
the planned transactions
 	Average interest earning assets at 1H23 $81.6bn17

-- 19 of 33 --

19
Appendix	3Q23 results
+71%
3Q23 financial highlights
Revenue 	$6.7bn 71%
(3Q22: $3.9bn)
ECL 	$(0.2)bn 28%
(3Q22: $(0.3)bn)
Costs 	$(3.7)bn (6)%
(3Q22: $(3.5)bn)
PBT 	$2.8bn >100%
(3Q22: $0.1bn)
RoTE 18 	37.3% 27.8ppts
(3Q22: 9.5%)
1,787 	1,961
4,374 	5,130 	5,020 	5,252 	5,282
(2,349)
122
3Q22
(8)
50
1,810
4Q22
2,049
30
1Q23
14
(20)1,957
2Q23
(253)	(204)
1,894
3Q23
3,934 6,982
9,060 7,203 	6,719
(7)%
Wealth and Personal Banking
Wealth Management
Personal Banking
Other
France disposal
Treasury disposal losses
Reported Wealth Balances, $bn
3Q23 vs. 3Q22
 Revenue up $2.8bn (71%). Excl. the $2.3bn France impairment in
3Q22 and $0.3bn Treasury disposal losses, up $0.7bn (11%).
Personal Banking NII up $0.9bn (23%) and Wealth up $0.1bn (6%)
across all products. Other down $0.3bn including $0.1bn New
Zealand loss on sale
 Customer lending up 1%. Incl. HFS balances, lending up $9bn
(2%). Mortgages up $6bn in Asia, $5bn UK, unsecured up $3bn
(Mexico and HK), Private Banking down $4bn due to deleveraging
and balances down $2bn due to the sale of Oman and Greece
 Customer accounts down 1%. Incl. HFS balances, deposits down
$3bn, primarily in the UK (rising cost of living and competition on
savings products) and the sale of Oman and Greece ($2bn), partly
offset by growth in Hong Kong, Singapore and mainland China
 Wealth balances up 12%. Excl. HFS impact, up 14% incl. NNIA of
$77bn, wealth deposits up $15bn and favourable market levels and
FX impacts of $115bn
3Q23 vs. 2Q23
 Revenue down $0.5bn (7%), incl. $0.3bn Treasury disposal losses
and adverse assumption changes in our insurance business
 Customer lending up $2bn. $4bn growth in mortgages (primarily
in Asia and the UK) was partly offset by deleveraging in Private
Banking ($2bn). Up $1bn incl. HFS balances due to the sale of
Oman and Greece ($1bn)
 Customer accounts down $3bn, primarily in the UK. Down $5bn
incl. HFS due to the sale of Oman and Greece ($2bn)
 Wealth balances up 1%. Excl. HFS impact, up 1%: NNIA of $34bn
partly offset by adverse market levels and FX impacts of $18bn
Revenue performance, $m
HFS
Portfolio
Balance sheet, $bn
3Q22 	2Q23 	3Q23
Customer lending
Customer accounts
804 	796 	793
24 	35 	32
828 	830 	825
967 1,097 	1,122
506
533 	527
18
3Q22
50
2Q23
48
3Q23
1,491
1,680 	1,697
Wealth deposits 4
Invested assets
HFS
Portfolio
449 	453 	455
25 	28 	28
474 	482 	483

-- 20 of 33 --

20
Appendix	3Q23 results
+22%
Commercial Banking
Balance sheet, $bn
Customer lending
Customer accounts
Revenue performance, $m
GPS
Credit & Lending
Markets products, Insurance
and Investments and Other
Treasury security disposals
3Q22
275503
1,401
2,683
4Q22
1,966‡
506
1,367
2,917
1Q23
585
510
1,372
493
2Q23
(190)
556‡
520
1,339
3,199
3Q23
527
1,453
1,968
4,441 4,862
6,756
5,504 	5,424
3,037
(1)%
3Q23 financial highlights
Revenue 	$5.4bn 22%
(3Q22: $4.4bn)
ECL 	$(0.7)bn 1%
(3Q22: $(0.7)bn)
Costs 	$(1.9)bn (15)%*
(3Q22: $(1.7)bn)
PBT 	$2.8bn 36%
(3Q22: $2.1bn)
RoTE 19 	25.8% 12.5ppts
(3Q22: 13.3%)
3Q23 vs. 3Q22
 Revenue up $1bn (22%), primarily due to growth in Asia and the
UK RFB. GPS up $1.2bn due to higher interest rates and business
repricing actions, partly offset by lower Credit & Lending due to
margins and balances in Asia, and $0.2bn notable Treasury
disposal losses
 Customer lending and accounts of $307bn and $460bn were
down 12% and 5% respectively. Including balances in HFS:
 	Lending down $17bn (5%) due to lower market-wide loan
demand in Hong Kong and the UK as a result of higher
interest rates and soft economic conditions which was partly
offset by Innovation Banking lending
 	Deposits broadly stable as market-wide reductions in the UK
and the sale of our Oman business ($2bn) were offset by
Innovation Banking deposits and inflows in the USA
3Q23 vs. 2Q23
 Revenue broadly stable as higher GPS revenue was offset by
$0.2bn Treasury disposal losses
 Customer lending down $6bn, primarily due to weaker market-
wide loan demand in Hong Kong
 Customer accounts broadly stable despite continued tightening
of global liquidity
482
462 	460
3Q22
23
2Q23
22
3Q23
485 	482
349
313 	307
3Q22
27
2Q23
25
3Q23
340 	332
HFS portfolio
6.0	6.9
o/w Innovation
Banking UK: 7.3	6.6
GTRF
* Costs up 15% due to Innovation Banking costs, higher performance-related pay accrual, the impact of Argentina hyperinflation and investment in technology, partly offset by our cost savings initiatives
‡ 1Q23: o/w $1.5bn preliminary gain on acquisition of SVB UK; 3Q23: o/w additional gain relating to SVB UK of $0.1bn
o/w Innovation
Banking UK:

-- 21 of 33 --

21
Appendix	3Q23 results
Global Banking and Markets
Management view of revenue
Key indicators
2,297 	1,943 2,540 	2,171 	2,158
1,703 1,935
2,133 2,135 	2,158
(490)	(206)
3Q22 	4Q22
(245)
1Q23
(289)
2Q23
(294)(135)
3Q23
3,794 	3,388
4,428 4,017 	3,887
+2% 	(3)%
MSS
Banking
Other
Treasury security disposals
Revenue performance, $m
$m 	3Q23 	∆3Q22
MSS 	2,158 	(6)%
Securities Services 	615 	18%
Global Debt Markets 	158 	44%
Global FX 	928 	(13)%
Equities 	167 	(39)%
Securities Financing 	302 	22%
XVAs 	(12) >(100)%
Banking 	2,158 	27%
GTRF 	164 	(5)%
GPS 	1,127 	41%
Credit & Lending 	506 	(4)%
Capital Markets &
Advisory 254 	40%
Other 	107 	>100%
GBM Other 	(429) >(100)%
Principal Investments 	1 	>100%
Other 	(430) >(100)%
Revenue 	3,887 	2%
3Q23 financial highlights
Revenue 	$3.9bn 2%
(3Q22: $3.8bn)
ECL 	$(0.2)bn (71)%
(3Q22: $(0.1)bn)
Costs 	$(2.4)bn (5)%
(3Q22: $(2.3)bn)
PBT 	$1.3bn (7)%
(3Q22: $1.4bn)
RoTE 20 	12.9% 1.3ppts
(3Q22: 11.6%)
3Q23 vs. 3Q22
 Revenue of $3.9bn, up $0.1bn (2%), including $0.1bn Treasury
disposal losses
 MSS revenue of $2.2bn, down $0.1bn (6%):
 	Global FX down vs. a strong 3Q22 but still benefitting from
higher client flows due to illiquid and volatile markets
 	Equities down due to lower volatility and client activity
 	Securities Services up from the benefit of higher rates; AUC up
10% vs. prior year
 	Securities Financing improved from higher client flows and
onboarding of new clients from strategic platform investments
 	Global Debt Markets up due to higher volumes and a normalised
market environment
 Banking revenue of $2.2bn, up $0.5bn (27%):
 	GPS up 41% due to higher interest rates and repricing actions
 	Capital Markets and Advisory up 40%, primarily due to increased
financing revenue
 	Credit & Lending down 4% due to weaker client demand
 Other down $0.2bn, including $0.1bn Treasury disposal losses
3Q23 vs. 2Q23
 Revenue down $0.1bn (3%), reflecting $0.1bn Treasury disposal
losses
 	MSS stable as higher client flows in Securities Financing and
Equities were offset by seasonal reductions in Global FX and
Global Debt Markets; Banking revenue and lending balances
stable
3Q23 ∆3Q22
Cost-income ratio, % 	62 	2ppts
Gross Capital Markets and
Advisory revenue 21, $m 379 	34%
Customer lending, $bn 	173 	(14)%
Customer deposits, $bn 	310 	(7)%
Assets under custody, $tn 	8.3 	10%
RWAs, $bn 	221 	(5)%

-- 22 of 33 --

22
Appendix	3Q23 results
3Q23 financial highlights
Revenue 	$131m >100%
(3Q22: $(594)m)
ECL 	$(1)m 100%
(3Q22: $1m)
Costs 	$54m >100%
(3Q22: $(457)m)
Associates 	$581m 8%
(3Q22: $540m)
PBT 	$765m >(100)%
(3Q22: $(510)m)
RoTE 20 	7.3% 5.0ppts
(3Q22: 2.3%)
Corporate Centre
Revenue performance, $m
452 546 	614 	647 470
133 110
118	93
(5)
3Q22
(1)
4Q22
(44)
1Q23
162 3
2Q23
(7)
3Q23
540
678 680
812
581
(28)%
Associate income detail, $m
3Q22 	4Q22 	1Q23 	2Q23 	3Q23
Central Treasury 	(352) 	(12) 	101 	(21) 	17
Legacy Portfolios 	(7) 	(177) 	(2) 	(9) 	7
Other 	(235) 	(223) 	(11) 	(87) 	107
Total 	(594) 	(412) 	88 	(117) 	131
Not included in Corporate Centre revenue: Markets
Treasury revenue allocated to global businesses
337	
277	
224	
183	
(497)
o/w: notable Treasury disposal losses	
—	
—	
—	
—	
(578)
BoCom 	Saudi Awwal Bank (SAB) 	Others
3Q23 vs. 2Q23
 Revenue up $248m, mainly favourable FV movements on FX
hedges related to the planned sale of our banking business in
Canada, partly offset by lower FX revaluation gains
 Associates down $231m, primarily BoCom due to lower profits in
2Q23; note we report Associate income one quarter in arrears
3Q23 vs. 3Q22
 Revenue up $725m, primarily in Central Treasury reflecting the non-
recurrence of $282m adverse movements on non-qualifying hedges
in 3Q22, FV gains on FX hedges related to the planned sale of our
banking business in Canada of $214m in 3Q23, and the non-
recurrence of $149m losses related to planned disposals in France
and Russia
 RWAs up $14bn, including RWAs on FX hedges related to the
planned sale of our banking business in Canada and higher associate
RWAs
RWAs (constant currency), $bn
47 54 	53
31
38 	39
3Q22 	2Q23 	3Q23
78
92 	92
+18% 	0%
Associates 	Other

-- 23 of 33 --

23
Appendix	3Q23 results
Shareholders’
equity, $bn
Tangible equity,
$bn
TNAV per share,
$
Basic number of ordinary
shares, millions
At 30 June 2023 	184.2 	153.2 	7.84 	19,534
Profit attributable to: 	6.1 	6.0 	0.31 	—
Ordinary shareholders 22 	5.6 	6.0 	0.31 	—
Other equity holders 	0.4 	— 	— 	—
Dividends 	(2.4) 	(2.0) 	(0.10) 	—
On ordinary shares 	(2.0) 	(2.0) 	(0.10) 	—
On other equity instruments 	(0.4) 	— 	— 	—
FX 22 	(2.8) 	(2.6) 	(0.13) 	—
Issuance/redemption of securities 	(1.7) 	— 	— 	—
Cancellation of shares/buybacks 23 	(2.0) 	(2.0) 	0.00 	(255)
Actuarial gains/(losses) on defined benefit plans 	(0.2) 	(0.2) 	(0.01) 	—
Cash flow hedge reserves 	1.0 	1.0 	0.05 	—
Fair value movements through ‘Other Comprehensive Income’ 	(0.2) 	(0.2) 	(0.01) 	—
Of which: changes in fair value arising from changes in own credit risk 	0.0 	0.0 	— 	—
Of which: Debt and Equity instruments at fair value through OCI 	(0.2) 	(0.2) 	(0.01) 	—
Other 22 	0.7 	0.2 	0.01 	(4)
At 30 September 2023 	182.7 	153.4 	7.96 	19,275
 Average basic number of shares outstanding during 3Q23: 19,404m
 On 30 October 2023, the Directors approved the cancellation of 325,273,407 ordinary shares held in treasury. A further announcement will follow once the treasury shares are
cancelled
 TNAV per share increased by $0.12 to $7.96, mainly due to profits, partly offset by adverse FX movements and dividends paid during the quarter
3Q23 vs. 2Q23 equity drivers

-- 24 of 33 --

24
Appendix	3Q23 results
(5,610)
58
Adjustment of
insurance / SPE’s
3,895	Allowable NCI in CET1
CET1 before
regulatory adjustments
(38,516)	Regulatory adjustments
CET1 capital
Total ordinary
shareholders’ equity
Additional Tier 1 	(17,719)
Total shareholders’
equity
Non-controlling interests 	(7,120)
Total equity
Foreseeable
dividend
189,840
182,720
165,001
163,344
124,828
Total shareholders’ equity to CET1 capital
3Q23 total equity to CET1 capital, $m 	Total equity to CET1 capital walk7, $m
3Q23 	2Q23 	1Q23
Total equity (per balance sheet) 	189,840 	191,651 	197,523
Non-controlling interests 	(7,120) 	(7,481) 	(7,428)
Total shareholders’ equity 	182,720 	184,170 	190,095
Additional Tier 1 	(17,719) 	(19,392) 	(19,392)
Total ordinary shareholders’ equity 	165,001 	164,778 	170,703
Foreseeable dividend 	(5,610) 	(4,887) 	(8,132)
Adjustment for insurance / SPE’s 	58 	(3) 	(3)
Allowable NCI in CET1 	3,895 	4,127 	4,192
CET1 before regulatory adjustments 	163,344 	164,015 	166,760
Prudential valuation adjustment 	(1,108) 	(1,076) 	(1,147)
Intangible assets 	(12,936) 	(12,875) 	(12,593)
Deferred tax asset deduction 	(3,986) 	(3,947) 	(4,343)
Cash flow hedge adjustment 	3,733 	4,686 	2,904
Excess of expected loss 	(2,130) 	(1,813) 	(1,618)
Own credit spread and debt valuation adjustment 	268 	290 	(369)
Defined benefit pension fund assets 	(5,305) 	(5,790) 	(5,948)
Direct and indirect holdings of CET1 instruments 	(40) 	(40) 	(40)
Other regulatory adjustments to CET1 capital (incl.
IFRS 9 transitional adjustments where relevant) (818) 	(724) 	(720)
Threshold deductions 	(16,194) 	(16,308) 	(17,200)
Regulatory adjustments 	(38,516) 	(37,597) 	(41,074)
CET1 capital 	124,828 	126,418 	125,686

-- 25 of 33 --

25
Appendix	3Q23 results
Balance sheet – customer lending
449 	453 	455
349 	313 	307
200 174 	173
0
3Q22
0
2Q23
0
3Q23
GBM
CMB
WPB
999
940 	936
Balances by global business, $bn
 	Customer lending of $936bn, broadly
stable (down $5bn) vs. 2Q23
 	WPB up $2bn, growth in mortgages in Asia
and the UK was partially offset by
deleveraging in Private Banking
 	CMB down $6bn (2%) due to weaker market-
wide loan demand in Hong Kong
 	GBM broadly stable as lower customer
activity in Asia was offset by higher loan
demand in Europe
 	CRE balances down $5.8bn on a reported
basis from FY22 to 1H23, notably relating to
mainland China and the USA. Further
reduction of $0.6bn in mainland China
balances in 3Q23
 	Cautious outlook on loan growth in the short
term; expect mid-single digit percentage
annual loan growth in the medium to long
term
Balances by entity
$453bn
$257bn
$53bn
$19bn
$936bn
$282bn
$109bn
$25bn
$19bn
Growth since 2Q23
Asia (HBAP)
UK RFB (HBUK)
USA (HNAH)
Mexico (HBMX)
Other
HSBC Bank plc
(HBEU)
o/w: Hong
Kong
HSBC Middle
East (HBME)
Total
59 	56	26
Total incl.
HFS 1,025 	999 	992
HFS
CC
$(9)bn
(2)%
$(7)bn
(3)%
$2bn
1 %
$1bn
1 %
$(0)bn
(0)%
$1bn
2 %
$(0)bn
(2)%
$1bn
6 %
$(5)bn
(0)%

-- 26 of 33 --

26
Appendix	3Q23 results
804 	793
482
796
460
335
462
310	306
0
3Q22
1
2Q23
0
3Q23
GBM
CMB
WPB
1,621 1,565 	1,563
Balance sheet – customer accounts
Balances by global business, $bn
 	Customer accounts of $1,563bn, broadly
stable vs. 2Q23
 	WPB broadly stable as outflows in the UK
were largely offset by inflows across Asia
 	CMB broadly stable despite continued
tightening of global liquidity
 	GBM up $4bn, primarily driven by growth in
HSBC Bank plc
 	Average GPS balances of $718bn were
down $10bn (1%) vs. 2Q23
 	UK RFB deposits of £266bn, up £50bn
(23%) vs. 4Q19
Balances by entity
Growth since 2Q23
$766bn
$325bn
$99bn
$31bn
$1,563bn
$528bn
$269bn
$28bn
$44bn
Asia (HBAP)
UK RFB (HBUK)
USA (HNAH)
Mexico (HBMX)
HSBC Bank plc
(HBEU)
Other
o/w: Hong
Kong
HSBC Middle
East (HBME)
Total
HFS 	65 	59	26
1,647 	1,630 	1,622
CC
$(6)bn
(1)%
$(1)bn
(0)%
$(7)bn
(2)%
$(2)bn
(1)%
$0bn
0 %
$1bn
2 %
$(0)bn
(1)%
$12bn*
39 %
$(2)bn
(0)%
* Other up primarily due to the transfer of $11.4bn deposits from HBEU to ‘Other Trading Entities’ as a result of intra-Group restructuring
Total incl.
HFS

-- 27 of 33 --

27
Appendix	3Q23 results
Global CRE exposures (1H23 and FY22 data)
1H23 Commercial real estate exposure, $m24
HBAP	
o/w HK 	HBUK 	HBEU 	HNAH 	HBMX 	HBME 	Other 	Total
Gross loans and
advances 59,560	
44,068 	14,805 	5,045 	4,643 	976 	1,604 	928 	87,561
o/w stage 1 	42,242	
30,218 	12,827 	4,181 	1,918 	877 	1,118 	839 	64,002
o/w stage 2 	13,588	
10,447 	1,385 	650 	2,662 	65 	313 	44 	18,707
o/w stage 3* 	3,730	
3,403 	593 	214 	63 	34 	173 	45 	4,852
Stage 3 as a % of
loans 6%	
8% 	4% 	4% 	1% 	3% 	11% 	5% 	6%
 	In more developed markets such as the UK and
Hong Kong, our exposure mainly comprises the
financing of investment assets, the redevelopment
of existing stock and the augmentation of both
commercial and residential markets to support
economic and population growth
 	At 1H23, Hong Kong exposure included exposure
to mainland China CRE of $8.1bn, which
accounted for $3.3bn of the $3.4bn stage 3
exposure
 	In less developed commercial real estate markets,
our exposures comprise lending for development
assets on relatively short tenors with a particular
focus on supporting larger, better capitalised
developers involved in residential construction or
assets supporting economic expansion
FY22 LTV analysis (fully collateralised exposure)25
69%
28%
25%
62%
2%
4%
Hong Kong
4%
6%
UK
<50% 	51-75% 	76-90% 	91-100%
Slide is on a reported basis
* Includes POCI

-- 28 of 33 --

28
Appendix	3Q23 results
EPS excluding material notable items and related impacts
$m 	3Q23 	2Q23 	3Q22 	YTD
PAOS 	5,619 	6,639 	2,002 	22,585
Provisional gain on acquisition of SVB UK 	(86) 	4 	— 	(1,593)
Impairment loss relating to France disposal (net of tax) 	— 	7 	1,852 	(1,622)
Impact of agreed Canada sale* 	(376) 	55 	— 	(439)
PAOS excluding material notable items 	5,157 	6,705 	3,854 	18,931
Average basic number of ordinary shares (m) 	19,404 	19,662 	19,752 	19,596
Basic EPS, $ 	0.29 	0.34 	0.10 	1.15
Basic EPS excluding material notable items, $ 	0.27 	0.34 	0.20 	0.97
* Represents the earnings recognised by the banking business in Canada, net of gains and losses on foreign exchange hedges held at Group level, that will reduce the gain on sale recognised by the Group on completion

-- 29 of 33 --

29
Appendix	3Q23 results
Glossary
AIEA 	Average interest earning assets
Banking NII
Banking net interest income is an alternative performance measure, and is defined as
Group net interest income after deducting: (1) the internal cost to fund trading and
fair value net assets for which associated revenue is reported in ‘Net income from
financial instruments held for trading or managed on a fair value basis’, also referred
to as ‘trading and fair value income’. These funding costs reflect proxy overnight or
term interest rates as applied by internal funds transfer pricing; (2) the funding cost of
foreign exchange swaps in Markets Treasury, where an offsetting income or loss is
recorded in trading and fair value income. These instruments are used to manage
foreign currency deployment and funding in our entities; (3) third-party net interest
income in our insurance business
BoCom 	Bank of Communications Co. Limited, an associate of HSBC
Bps 	Basis points. One basis point is equal to one-hundredth of a percentage point
CER 	Cost-efficiency ratio
CET1 	Common Equity Tier 1
Corporate Centre
(CC)
Corporate Centre comprises Central Treasury, our legacy businesses, interests in our
associates and joint ventures and central stewardship costs
CMB 	Commercial Banking, a global business
CSM
Contractual Service Margin, a component of the carrying amount of a group of
insurance contract assets or liabilities which represents the unearned profit which the
Group will recognise as it provides insurance contract services under the insurance
contracts in the Group
CRE 	Commercial Real Estate
DPS 	Dividend per share
ECL
Expected credit losses. In the income statement, ECL is recorded as a change in
expected credit losses and other credit impairment charges. In the balance sheet, ECL
is recorded as an allowance for financial instruments to which only the impairment
requirements in IFRS 9 are applied
EPS 	Earnings per share
FVOCI 	Fair value through other comprehensive income
GBM 	Global Banking and Markets, a global business
GPS 	Global Payments Solutions (formerly GLCM: Global Liquidity and Cash Management)
Group 	HSBC Holdings plc and its subsidiary undertakings
GTRF 	Global Trade and Receivables Finance
HFS 	Held-for-sale
HQLA 	High-quality liquid assets
IFRS 	International Financial Reporting Standard
Innovation
Banking Includes HSBC Innovation Bank Limited and related international operations
LTV 	Loan to value
Markets Treasury Execution arm of HSBC's Treasury function, responsible for cash and liquidity
management, funding, and management of structural interest rate risk of the Group
MSS 	Markets and Securities Services
NAV 	Net asset value
NCI 	Non-controlling interests
NII 	Net interest income
NIM 	Net interest margin
NNIA 	Net new invested assets
PAOS 	Profit attributable to ordinary shareholders
PBT 	Profit before tax
POCI 	Purchased originated credit impaired
Ppt 	Percentage points
PRP 	Performance related pay
SAB 	Saudi Awwal Bank, an associate of HSBC
SVB UK 	Silicon Valley Bank UK, now HSBC Innovation Bank Limited
RoTE 	Return on average tangible equity
RWA 	Risk-weighted asset
TNAV 	Tangible net asset value
UK RFB / RFB HSBC UK, the UK ring-fenced bank, established July 2018 as part of ring fenced bank
legislation
WPB 	Wealth and Personal Banking, a global business
XVAs 	Credit and Funding Valuation Adjustments

-- 30 of 33 --

30
Appendix	3Q23 results
Footnotes
1. 	RoTE excluding the impact of strategic transactions (the planned sale of our retail banking operations in France
and the acquisition of SVB UK), annualised. Annualised RoTE including strategic transactions is 19.7% for 9M23
and 9.4% for 9M22
2. 	Wholesale transaction banking revenue comprises Global Payments Solutions, Global Trade and Receivables
Finance, Securities Services and FX (GFX in GBM management view of income and GFX in CMB from cross sale
of FX to CMB clients includes within 'Markets products, Insurance and Investments and Other‘). GFX includes
our emerging markets business
3. 	Balances are shown on a reported FX basis. Excludes wealth balances in held-for-sale
4. 	Wealth deposits include Premier, Jade and Global Private Banking deposits, which include Prestige deposits in
Hang Seng Bank, and form part of the total WPB customer accounts balance
5. 	Reported FX basis
6. 	Notable items in 3Q22 included a $2.5bn impairment relating to the planned sale of our retail banking operations
in France, $0.7bn restructuring and other related costs and adverse fair value movements on financial
instruments of $0.3bn
7. 	Unless otherwise stated, regulatory capital ratios and requirements are on a reported basis, and are based on the
transitional arrangements of the Capital Requirements Regulation in force at the time. Leverage metrics exclude
central bank claims in accordance with the Prudential Regulation Authority's (‘PRA‘) UK leverage framework.
References to EU regulations and directives (including technical standards) should, as applicable, be read as
references to the UK‘s version of such regulation or directive, as onshored into UK law under the European
Union (Withdrawal) Act 2018, and as may be subsequently amended under UK law
8. 	Banking NII is defined as Group NII excluding the central costs of funding trading and fair value income and third
party insurance NII. For full analysis, please see the glossary and HSBC Holdings plc 3Q23 Earnings Release
9. 	The centrally allocated funding costs associated with funding net income from financial instruments held for
trading or managed on a fair value basis results in an interest expense to Group NII which is fully offset by non-
NII which is reported in Corporate Centre
10. Including held-for-sale balances
11. Regulatory profits
12. RoTE target is subject to the current market-implied path for global policy rates. Excludes the impact of strategic
transactions
13. Based on tangible equity (‘TE’) of the Group’s major legal entities excluding associates, holding companies and
consolidation adjustments. Asia refers to The Hongkong and Shanghai Banking Corporation (HBAP)
14. Medium term is defined as 3-4 years from 1 January 2020; long term is defined as 5-6 years from 1 January
2020
15. For the purposes of computing our dividend payout ratio target, we exclude from earnings per share material
notable items, comprising the impacts of the planned sale of our retail banking operations in France, the agreed
sale of our banking business in Canada and the provisional gain following the acquisition of SVB UK. We also
exclude HSBC Bank Canada‘s financial results from the 30 June 2022 net asset reference date until completion,
as the gain on sale will be recognised through a combination of the consolidation of HSBC Bank Canada‘s
results in the Group‘s results since this date, and the remaining gain on sale recognised at completion
16. Notable items shown on a constant currency basis, see slide 16 for notable items as reported
17. Converted from CAD109,621m as reported in HSBC Bank Canada’s Second Quarter 2023 Interim Report, using
an average CAD/USD rate of 0.74476
18. RoTE (annualised) in 9M23 included a 6.6 percentage point favourable impact from the reversal of the
impairment losses relating to the planned sale of our retail banking operations in France
19. RoTE (annualised) in 9M23 included a 4.3 percentage point favourable impact from the provisional gain on the
acquisition of SVB UK
20. RoTE is YTD annualised
21. Includes revenue shared with Markets and Securities Services and CMB
22. Differences between shareholders’ equity and tangible equity drivers primarily reflect goodwill and other
intangible impairment and amortisation expense within ‘Profit Attributable to Ordinary shareholders’, FX on
goodwill and intangibles within ‘FX’, and intangible additions and other movements within ‘Other’
23. Shareholders equity and tangible equity reflect the full $2bn buyback announced at 2Q23. The change in shares
reflects the shares repurchased and cancelled during the quarter but does not include shares repurchased and
cancelled after 30 September
24. Based on the loan purpose for on balance sheet exposures only
25. This disclosure is updated on an annual basis and is correct for FY22. Figures are based on the industry sector of
the obligor / borrower including both on and off balance sheet exposures. Total for Hong Kong $36.2bn, UK
$12.7bn

-- 31 of 33 --

31
Appendix	3Q23 results
Disclaimer
Important notice
The information, statements and opinions set out in this presentation and accompanying discussion (this “Presentation”) are for informational and reference purposes only and do not constitute a public offer for the purposes of any applicable law or
an offer to sell or solicitation of any offer to purchase any securities or other financial instruments or any advice or recommendation in respect of such securities or other financial instruments.
This Presentation, which does not purport to be comprehensive nor render any form of legal, tax, investment, accounting, financial or other advice, has been provided by HSBC Holdings plc (together with its consolidated subsidiaries, the “Group”) and
has not been independently verified by any person. You should consult your own advisers as to legal, tax investment, accounting, financial or other related matters concerning any investment in any securities. No responsibility, liability or obligation
(whether in tort, contract or otherwise) is accepted by the Group or any member of the Group or any of their affiliates or any of its or their officers, employees, agents or advisers (each an “Identified Person”) as to or in relation to this Presentation
(including the accuracy, completeness or sufficiency thereof) or any other written or oral information made available or any errors contained therein or omissions therefrom, and any such liability is expressly disclaimed.
No representations or warranties, express or implied, are given by any Identified Person as to, and no reliance should be placed on, the accuracy or completeness of any information contained in this Presentation, any other written or oral information
provided in connection therewith or any data which such information generates. No Identified Person undertakes, or is under any obligation, to provide the recipient with access to any additional information, to update, revise or supplement this
Presentation or any additional information or to remedy any inaccuracies in or omissions from this Presentation. Past performance is not necessarily indicative of future results. Differences between past performance and actual results may be material
and adverse.
Forward-looking statements
This Presentation may contain projections, estimates, forecasts, targets, opinions, prospects, results, returns and forward-looking statements with respect to the financial condition, results of operations, capital position, strategy and business of the
Group which can be identified by the use of forward-looking terminology such as “may”, “will”, “should”, “expect”, “anticipate”, “project”, “plan”, “estimate”, “seek”, “intend”, “target”, “believe”, "potential" and "reasonably possible" or the negatives
thereof or other variations thereon or comparable terminology (together, “forward-looking statements”), including the strategic priorities and any financial, investment and capital targets and any ESG related targets, commitments and ambitions
described herein. Any such forward-looking statements are not a reliable indicator of future performance, as they may involve significant stated or implied assumptions and subjective judgements which may or may not prove to be correct. There can
be no assurance that any of the matters set out in forward-looking statements are attainable, will actually occur or will be realised or are complete or accurate. The assumptions and judgments may prove to be incorrect and involve known and
unknown risks, uncertainties, contingencies and other important factors, many of which are outside the control of the Group. Actual achievements, results, performance or other future events or conditions may differ materially from those stated,
implied and/or reflected in any forward-looking statements due to a variety of risks, uncertainties and other factors (including without limitation those which are referable to general market or economic conditions, regulatory changes, increased
volatility in interest rates and inflation levels and other macroeconomic risks, geopolitical tensions such as the Russia-Ukraine war or the Israel-Hamas war and potential further escalations, specific economic developments, such as the uncertain
performance of the commercial real estate sector in mainland China, or as a result of data limitations and changes in applicable methodologies in relation to ESG related matters). Any such forward-looking statements are based on the beliefs,
expectations and opinions of the Group at the date the statements are made, and the Group does not assume, and hereby disclaims, any obligation or duty to update, revise or supplement them if circumstances or management’s beliefs, expectations
or opinions should change. For these reasons, recipients should not place reliance on, and are cautioned about relying on, any forward-looking statements. No representations or warranties, expressed or implied, are given by or on behalf of the Group
as to the achievement or reasonableness of any projections, estimates, forecasts, targets, commitments, ambitions, prospects or returns contained herein.
Additional detailed information concerning important factors, including but not limited to ESG related factors, that could cause actual results to differ materially from this Presentation is available in our Annual Report and Accounts for the fiscal year
ended 31 December 2022 filed with the Securities and Exchange Commission (the “SEC”) on Form 20-F on 22 February 2023 (the “2022 Form 20-F”), our 1Q 2023 Earnings Release furnished with the SEC on Form 6-K on 2 May 2023 (the “1Q 2023
Earnings Release”), our Interim Financial Report for the six months ended 30 June 2023, furnished with the SEC on Form 6-K on 1 August 2023 (the “2023 Interim Report”) and our 3Q 2023 Earnings Release, which we expect to furnish with the SEC
on Form 6-K on 30 October 2023 (the “3Q 2023 Earnings Release”).
Alternative Performance Measures
This Presentation contains non-IFRS measures used by management internally that constitute alternative performance measures under European Securities and Markets Authority guidance and non-GAAP financial measures defined in and presented
in accordance with SEC rules and regulations (“Alternative Performance Measures”). The primary Alternative Performance Measures we use are presented on a “constant currency” basis which is computed by adjusting comparative period reported
results for the effects of foreign currency translation differences, which distort period-on-period comparisons.
Reconciliations between Alternative Performance Measures and the most directly comparable measures under IFRS are provided in our 1Q 2023 Earnings Release, our 2023 Interim Report and our 3Q 2023 Earning Release, when filed, each of which
is available at www.hsbc.com.
Information in this Presentation was prepared as at 30 October 2023.

-- 32 of 33 --



-- 33 of 33 --